Wissenschaftliche Publikationen zu COVID-19

Vergleichsstudie zur Aussagekraft eines rekombinanten Lineblots als SARS-CoV-2-IgG-Abklärungstest - Journal of Laboratory Medicine

Wellinghausen, N., Ivanova, R., Deininger, S., & Götz, A. (2020). Comparative study of a new commercial recombinant line assay and two immunoassays for detection of SARS-CoV-2 IgG antibodies in PCR-confirmed outpatients, Journal of Laboratory Medicine (published online ahead of print 2020), 000010151520200095. doi: https://doi.org/10.1515/labmed-2020-0095
>> Zur Publikation.

Methodenvergleich zur Antikörper-Antwort - GMS Infectious Diseases

Wellinghausen N, Voss M, Ivanova R, Deininger S. Evaluation of the SARS-CoV-2-IgG response in outpatients by five commercial immunoassays. GMS Infect Dis. 2020;8:Doc22, doi: 10.3205/id000066, URN: urn:nbn:de:0183-id0000666.
>> Zur Publikation.

Antikörper-Antwort gegen SARS-CoV-2-IgG - Journal of Clinical Virology

Wellinghausen N, Plonné D, Voss M, Ivanova R, Frodl R, Deininger S. SARS-CoV-2-IgG response is different in COVID-19 outpatients and asymptomatic contactpersons, Journal of Clinical Virology (2020), doi:https://doi.org/10.1016/j.jcv.2020.104542
>> Zur Publikation.